{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:06:25Z","timestamp":1777601185604,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jfo.2013.04.005","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T18:15:18Z","timestamp":1382120118000},"page":"779-788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Atteintes oculaires des neuropathies amylo\u00efdes h\u00e9r\u00e9ditaires li\u00e9es \u00e0 la transthyr\u00e9tine"],"prefix":"10.1016","volume":"36","author":[{"given":"A.","family":"Rousseau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kaswin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Adams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cauquil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Th\u00e9audin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Mincheva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"M\u2019Garrech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Labetoulle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Barreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2013.04.005_bib0005","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1749-6632.1984.tb13742.x","article-title":"Family studies of the genetic abnormality in transthyretin (prealbumin) in Portuguese patients with familial amyloidotic polyneuropathy","volume":"435","author":"Saraiva","year":"1984","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jfo.2013.04.005_bib0010","unstructured":"Sekijima Y. Familial Transthyretin Amyloidosis [GeneReviews\u2122. 1993\u20132012]\u00a0\u2013\u00a0PubMed\u00a0\u2013\u00a0NCBI. GeneReviews\u2122 [Internet]. Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, editors. Disponible sur\u00a0: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20301373 [cit\u00e9 20.10.2012]."},{"key":"10.1016\/j.jfo.2013.04.005_bib0015","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plant\u00e9-Bordeneuve","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0959-440X(98)80016-X","article-title":"The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways","volume":"8","author":"Kelly","year":"1998","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0025","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0959-440X(99)00049-4","article-title":"Amyloid fibrillogenesis: themes and variations","volume":"10","author":"Rochet","year":"2000","journal-title":"Curr Opin Struct Biol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0030","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2005.01.018","article-title":"The biological and chemical basis for tissue-selective amyloid disease","volume":"121","author":"Sekijima","year":"2005","journal-title":"Cell"},{"issue":"Suppl 1","key":"10.1016\/j.jfo.2013.04.005_bib0035","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/13506129.2012.665400","article-title":"Genotype\u00a0\u2013\u00a0phenotype correlation in FAP","volume":"19","author":"Zeldenrust","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.jfo.2013.04.005_bib0040","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/brain\/123.7.1495","article-title":"The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation","volume":"123","author":"Adams","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.jfo.2013.04.005_bib0045","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.lpm.2011.11.027","article-title":"[Treatment of familial amyloid polyneuropathy]","volume":"41","author":"Adams","year":"2012","journal-title":"Presse Med"},{"key":"10.1016\/j.jfo.2013.04.005_bib0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.lpm.2009.02.021","article-title":"[Liver transplantation for familial amyloid polyneuropathy]","volume":"39","author":"Adams","year":"2010","journal-title":"Presse Med"},{"key":"10.1016\/j.jfo.2013.04.005_bib0055","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1600-0420.2007.01098.x","article-title":"Ocular manifestations in liver transplant recipients with familial amyloid polyneuropathy","volume":"86","author":"Sandgren","year":"2008","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0060","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/bjo.81.4.295","article-title":"Ocular manifestations of familial amyloidotic polyneuropathy type I: long-term follow up","volume":"81","author":"Ando","year":"1997","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0065","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/01.TP.0000111516.60013.E6","article-title":"A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation","volume":"77","author":"Ando","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.jfo.2013.04.005_bib0070","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/13506120009146440","article-title":"Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin","volume":"7","author":"Munar-Qu\u00e9s","year":"2000","journal-title":"Amyloid"},{"key":"10.1016\/j.jfo.2013.04.005_bib0075","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/00007890-199610150-00028","article-title":"De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation","volume":"62","author":"Ando","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.jfo.2013.04.005_bib0080","doi-asserted-by":"crossref","first-page":"247","DOI":"10.3109\/13506120209114101","article-title":"Presence of variant transthyretin in aqueous humor of a patient with familial amyloidotic polyneuropathy after liver transplantation","volume":"9","author":"Haraoka","year":"2002","journal-title":"Amyloid"},{"key":"10.1016\/j.jfo.2013.04.005_bib0085","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1001\/archophthalmol.2009.390","article-title":"Impact of liver transplantation on transthyretin-related ocular amyloidosis in Japanese patients","volume":"128","author":"Hara","year":"2010","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0090","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/0304-4165(95)00079-Q","article-title":"Protein synthesis and secretion by cultured retinal pigment epithelia","volume":"1245","author":"Jaworowski","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jfo.2013.04.005_bib0095","first-page":"497","article-title":"The retinal pigment epithelium is the unique site of transthyretin synthesis in the rat eye","volume":"31","author":"Cavallaro","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2013.04.005_bib0100","first-page":"489","article-title":"Distribution of transthyretin in the rat eye","volume":"31","author":"Dwork","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jfo.2013.04.005_bib0105","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.exer.2005.02.003","article-title":"Transthyretin synthesis in rabbit ciliary pigment epithelium","volume":"81","author":"Kawaji","year":"2005","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.jfo.2013.04.005_bib0110","series-title":"Lacrymal dysfunction in familial amyloid polyneuropathy (FAP), swedish type familial amyloid polyneuropathy and other transthyretin related disorders. Arquivos de medicina","first-page":"329","author":"Sandgren","year":"1990"},{"key":"10.1016\/j.jfo.2013.04.005_bib0115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0039-6257(95)80025-5","article-title":"Ocular amyloidosis, with special reference to the hereditary forms with vitreous involvement","volume":"40","author":"Sandgren","year":"1995","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0120","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1001\/archopht.121.3.351","article-title":"Secondary glaucoma in patients with familial amyloidotic polyneuropathy","volume":"121","author":"Kimura","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0125","doi-asserted-by":"crossref","unstructured":"Methodologies to diagnose and monitor dry eye disease: report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:108\u201352.","DOI":"10.1016\/S1542-0124(12)70083-6"},{"key":"10.1016\/j.jfo.2013.04.005_bib0130","doi-asserted-by":"crossref","unstructured":"The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf 2007;5:75\u201392.","DOI":"10.1016\/S1542-0124(12)70081-2"},{"issue":"1","key":"10.1016\/j.jfo.2013.04.005_bib0135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ana.410040115","article-title":"Pharmacological studies of the pupils in familial amyloid polyneuropathy","volume":"4","author":"Okajima","year":"1978","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0140","first-page":"212","article-title":"[Neuro-paralytic keratitis in familial Portuguese amyloidosis of the Corino-Andrade type]","volume":"97","author":"Rasteiro","year":"1986","journal-title":"Bull Mem Soc Fr Ophtalmol"},{"issue":"223","key":"10.1016\/j.jfo.2013.04.005_bib0145","first-page":"226","article-title":"[A case of spontaneous corneal perforation in De Andrade's Portuguese amyloidosis]","volume":"88","author":"Abenhaim","year":"1988","journal-title":"Bull Soc Ophtalmol Fr"},{"key":"10.1016\/j.jfo.2013.04.005_bib0150","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00417-004-0996-6","article-title":"Bilateral corneal perforation in familial amyloidotic polyneuropathy","volume":"243","author":"Dosso","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0155","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0008-4182(04)80071-1","article-title":"Correlation between corneal sensitivity, subjective dry eye symptoms and corneal staining in Sj\u00f6gren's syndrome","volume":"39","author":"Adatia","year":"2004","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0315","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5301\/ejo.5000197","article-title":"Topical cyclosporine for severe dry eye disease in liver-transplanted Portuguese patients with familial amyloidotic polyneuropathy (ATTRV30M)","volume":"23","author":"Beir\u00e3o","year":"2013","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0165","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/S0161-6420(99)00726-5","article-title":"Ocular amyloidosis and secondary glaucoma","volume":"106","author":"Nelson","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2013.04.005_bib0170","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1159\/000308666","article-title":"Secondary glaucoma accompanied with primary familial amyloidosis","volume":"175","author":"Tsukahara","year":"1977","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.jfo.2013.04.005_bib0175","series-title":"Forty years of experience with type 1\u00a0amyloid neuropathy. Review of 483\u00a0cases. Amyloid and amyloidosis. Excepta Medica","first-page":"88","author":"Coutinho","year":"1980"},{"key":"10.1016\/j.jfo.2013.04.005_bib0180","first-page":"217","article-title":"[Familial amyloid polyneuropathy type I complicated by chronic glaucoma: 3\u00a0cases]","volume":"23","author":"Frau","year":"2000","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0185","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/bjo.2005.082735","article-title":"Ocular decompression retinopathy following trabeculectomy with mitomycin C associated with familial amyloidotic polyneuropathy","volume":"90","author":"Wakita","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0190","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1046\/j.1442-9071.2002.00539.x","article-title":"Familial amyloidotic polyneuropathy presenting with rubeotic glaucoma","volume":"30","author":"Dunlop","year":"2002","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0195","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1006\/jsbi.2000.4289","article-title":"Modulating factors in amyloid-\u03b2 fibril formation","volume":"130","author":"McLaurin","year":"2000","journal-title":"J Struct Biol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0200","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/13506129909007312","article-title":"Analysis of transthyretin amyloid fibrils from vitreous samples in familial amyloidotic polyneuropathy (Val30Met)","volume":"6","author":"Ando","year":"1999","journal-title":"Amyloid"},{"key":"10.1016\/j.jfo.2013.04.005_bib0205","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/13506129.2010.527068","article-title":"Transthyretin-related vitreous amyloidosis in different endemic areas","volume":"17","author":"Kawaji","year":"2010","journal-title":"Amyloid"},{"key":"10.1016\/j.jfo.2013.04.005_bib0210","first-page":"197","article-title":"Vitreous amyloidosis in familial amyloidotic polyneuropathy","volume":"40","author":"Ciulla","year":"1995","journal-title":"Report of a case with the Val30Met transthyretin mutation. Surv Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0215","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1600-0420.2004.00289.x","article-title":"Vitreous opacities in a case of familial amyloidotic polyneuropathy associated with a transthyretin Lys 54","volume":"82","author":"Imasawa","year":"2004","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1016\/j.jfo.2013.04.005_bib0220","first-page":"1776","article-title":"Amyloidosis of the vitreous","volume":"100","author":"Savage","year":"1982","journal-title":"Fluorescein angiographic findings and association with neovascularization. Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0225","first-page":"41","article-title":"Vitreous opacities in primary amyloid disease","volume":"60","author":"Hitchings","year":"1976","journal-title":"A clinical, histochemical, and ultrastructural report. Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0230","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0002-9394(02)01838-X","article-title":"Vitreous opacities and outcome of vitreous surgery in patients with familial amyloidotic polyneuropathy","volume":"135","author":"Koga","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0235","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1080\/13506120400015580","article-title":"A case of vitreous amyloidosis without systemic symptoms in familial amyloidotic polyneuropathy","volume":"11","author":"Kawaji","year":"2004","journal-title":"Amyloid"},{"key":"10.1016\/j.jfo.2013.04.005_bib0240","first-page":"e33","article-title":"Eagle RC Jr, Fine HF, Cunningham ET Jr","volume":"114","author":"Roe","year":"2007","journal-title":"Oculoleptomeningeal amyloidosis in a patient with a TTR Val30Gly mutation in the transthyretin gene. Ophthalmology"},{"key":"10.1016\/j.jfo.2013.04.005_bib0245","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3129\/i09-023","article-title":"Oculoleptomeningeal amyloidosis in 3\u00a0individuals with the transthyretin variant Tyr69His","volume":"44","author":"Schweitzer","year":"2009","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0250","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1212\/01.WNL.0000065901.18353.AB","article-title":"Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His","volume":"60","author":"v50] Blevins","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.jfo.2013.04.005_bib0255","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1212\/01.wnl.0000250343.34110.79","article-title":"Familial oculoleptomeningeal amyloidosis associated with primary angiitis of the CNS","volume":"68","author":"Dowell","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.jfo.2013.04.005_bib0260","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1212\/01.wnl.0000178983.20975.af","article-title":"Neuroradiologic and clinicopathologic features of oculoleptomeningeal type amyloidosis","volume":"65","author":"Nakamura","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.jfo.2013.04.005_bib0265","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1212\/WNL.47.4.988","article-title":"Massive leptomeningeal amyloidosis associated with a Val30Met transthyretin gene","volume":"47","author":"Herrick","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.jfo.2013.04.005_bib0270","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0161-6420(87)33402-5","article-title":"Pars plana vitrectomy for vitreous amyloidosis","volume":"94","author":"Doft","year":"1987","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2013.04.005_bib0275","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/art.1780290323","article-title":"Scalloped pupils in familial amyloid polyneuropathy","volume":"29","author":"Rubinow","year":"1986","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jfo.2013.04.005_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00166754","article-title":"Ocular microangiopathy in familial amyloidotic polyneuropathy, type I","volume":"230","author":"Ando","year":"1992","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0285","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0021-5155(02)00626-3","article-title":"Choroidal vascular lesions identified by ICG angiography in a case of familial amyloidotic polyneuropathy","volume":"47","author":"Kojima","year":"2003","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.jfo.2013.04.005_bib0290","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/j.ophtha.2005.05.028","article-title":"Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C","volume":"112","author":"Kawaji","year":"2005","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2013.04.005_bib0295","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3109\/13506129.2012.724035","article-title":"Familial amyloid polyneuropathy associated with the novel transthyretin variant Arg34Gly","volume":"19","author":"Levy","year":"2012","journal-title":"Amyloid"},{"key":"10.1016\/j.jfo.2013.04.005_bib0300","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jns.2008.05.014","article-title":"A new Thr49Pro transthyretin gene mutation associated with leptomeningeal amyloidosis","volume":"272","author":"Nakagawa","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jfo.2013.04.005_bib0305","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.jfo.2013.04.005_bib0310","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ophtha.2009.07.042","article-title":"Novel therapy for transthyretin-related ocular amyloidosis: a pilot study of retinal laser photocoagulation","volume":"117","author":"Kawaji","year":"2010","journal-title":"Ophthalmology"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551213002465?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551213002465?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:04:15Z","timestamp":1759259055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551213002465"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":62,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0181551213002465"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2013.04.005","relation":{},"ISSN":["0181-5512"],"issn-type":[{"value":"0181-5512","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atteintes oculaires des neuropathies amylo\u00efdes h\u00e9r\u00e9ditaires li\u00e9es \u00e0 la transthyr\u00e9tine","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2013.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}